Nothing Special   »   [go: up one dir, main page]

CO2019008347A2 - Quick release composition of cinitapride and simethicone and process to prepare it - Google Patents

Quick release composition of cinitapride and simethicone and process to prepare it

Info

Publication number
CO2019008347A2
CO2019008347A2 CONC2019/0008347A CO2019008347A CO2019008347A2 CO 2019008347 A2 CO2019008347 A2 CO 2019008347A2 CO 2019008347 A CO2019008347 A CO 2019008347A CO 2019008347 A2 CO2019008347 A2 CO 2019008347A2
Authority
CO
Colombia
Prior art keywords
simethicone
cinitapride
prepare
quick release
release composition
Prior art date
Application number
CONC2019/0008347A
Other languages
Spanish (es)
Inventor
José Luis Lauria
Original Assignee
Rhein Siegfried Sa De Cv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhein Siegfried Sa De Cv filed Critical Rhein Siegfried Sa De Cv
Publication of CO2019008347A2 publication Critical patent/CO2019008347A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica de administración oral, bajo la forma de cápsulas con contenido líquido, que comprende una combinación a dosis fija de Cinitaprida tartrato y Simeticona junto con al menos un agente surfactante y opcionalmente uno o más excipientes farmacéuticamente aceptables, y el proceso para obtener dicha composición.The present invention relates to a pharmaceutical composition for oral administration, in the form of capsules with liquid content, comprising a fixed dose combination of Cinitapride tartrate and Simethicone together with at least one surfactant and optionally one or more pharmaceutically acceptable excipients, and the process to obtain said composition.

CONC2019/0008347A 2017-02-07 2019-07-30 Quick release composition of cinitapride and simethicone and process to prepare it CO2019008347A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MX2017001714A MX2017001714A (en) 2017-02-07 2017-02-07 Rapid-release composition of cinitapride and simeticone and method for preparing same.
PCT/IB2018/050528 WO2018146575A1 (en) 2017-02-07 2018-01-29 Rapid-release composition of cinitapride and simeticone and method for preparing same

Publications (1)

Publication Number Publication Date
CO2019008347A2 true CO2019008347A2 (en) 2019-08-30

Family

ID=63108046

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2019/0008347A CO2019008347A2 (en) 2017-02-07 2019-07-30 Quick release composition of cinitapride and simethicone and process to prepare it

Country Status (10)

Country Link
AR (1) AR110797A1 (en)
BR (1) BR112019015989A2 (en)
CL (1) CL2019001944A1 (en)
CO (1) CO2019008347A2 (en)
CR (1) CR20190402A (en)
DO (1) DOP2019000190A (en)
EC (1) ECSP19051198A (en)
MX (1) MX2017001714A (en)
PE (1) PE20191491A1 (en)
WO (1) WO2018146575A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6676933B2 (en) * 2001-05-23 2004-01-13 Osmotica Corp. Pharmaceutical composition containing mosapride and pancreatin
EP1596838A2 (en) * 2003-02-11 2005-11-23 Torrent Pharmaceuticals Ltd Once a day orally administered pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent
CN101065115A (en) * 2004-11-24 2007-10-31 默克公司 Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide
WO2009066146A2 (en) * 2007-11-19 2009-05-28 Cadila Pharmaceuticals Ltd. Stable solutions of sparingly soluble actives

Also Published As

Publication number Publication date
AR110797A1 (en) 2019-05-02
PE20191491A1 (en) 2019-10-21
ECSP19051198A (en) 2019-07-31
CL2019001944A1 (en) 2019-12-06
CR20190402A (en) 2019-09-20
DOP2019000190A (en) 2019-10-15
MX2017001714A (en) 2018-08-06
BR112019015989A2 (en) 2020-03-31
WO2018146575A1 (en) 2018-08-16

Similar Documents

Publication Publication Date Title
DOP2018000297A (en) DERIVATIVE OF GLUCAGON, CONJUGATE OF THE SAME, COMPOSITION THAT INCLUDES THE SAME AND THERAPEUTIC USE OF THE SAME
CO2019008364A2 (en) Pharmaceutical compositions comprising meloxicam
CY1124052T1 (en) ORALLY DISPERSIBLE TABLET CONTAINING ESTETROL
ECSP16084317A (en) PHARMACEUTICAL FORMULATIONS, PREPARATION PROCESSES AND METHODS OF USE
SV2017005595A (en) ORODISPERSABLE DOSAGE UNIT CONTAINING A STETROL COMPONENT
PE20151301A1 (en) PHARMACEUTICAL FORMULATIONS RESISTANT TO IMPROPER HANDLING
AR091351A1 (en) BROMOCRIPTINE FORMULATIONS, METHOD FOR IMPROVING GLUCEMIC CONTROL AND METHOD FOR MANUFACTURING
CL2017001483A1 (en) Fixed ratio formulation of insulin glargine / lixisenatide
AR094707A1 (en) COMPOUND OF QUINAZOLIN-4-AMINA, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE FOR THE TREATMENT OF A DISEASE MEDIATED BY THE RIP2 KINASE
EA201991265A1 (en) MEDICINAL FORMS WITH DELAYED DELIVERY CONTAINING DIMETHYLFUMARATE
ECSP16005208A (en) STABLE ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION IN A FORM OF A COATED TABLET INCLUDING ISONIAZID GRANULES AND RIFAPENTINE GRANULES AND THEIR PREPARATION PROCESS
CO2019008347A2 (en) Quick release composition of cinitapride and simethicone and process to prepare it
ECSP15033649A (en) A COMBINED MEDICINAL PRODUCT INCLUDING PHENYLEPHRINE AND PARACETAMOL
MX2015003956A (en) Pharmaceutical composition comprising micronized pinaverium bromide and simeticone.
CO2019013645A2 (en) Dropropizine in combination with ambroxol in the dosage form of syrup and tablets
CL2017000026A1 (en) Pharmaceutical dosage forms
AR099330A1 (en) USE OF PARICALCITOL IN THE TREATMENT OF INFLAMMATORY ANEMIA
CO2019006693A2 (en) Improved composition of lansoprazole and simethicone and process to prepare it
EA201691763A1 (en) STABLE, QUICKLY SOLUBLE DOSE FORM, CONTAINING AMOXICILLIN AND STOPPING ACID
CO2021000158A2 (en) Pharmaceutical composition containing a peptide
AR114006A1 (en) PHARMACEUTICAL COMBINATION IN THE FORM OF TWO-LAYER TABLETS THAT INCLUDE KETOROLACO TROMETAMINE AND TRAMADOL HYDROCHLORIDE, AND ITS USE FOR THE TREATMENT OF PAIN
ECSP19044926A (en) IMPROVED COMPOSITION OF LANSOPRAZOLE AND SYMETICONE AND PROCESS FOR PREPARING
CU20130165A7 (en) MODIFIED RELEASE OF 4-METHYL-3 - [[- 4- (3- PIRIDINIL) -2-PYRIMIDINYL] AMINO] -N-5- (4- METHYL-1H-IMIDAZOL-1- IL) -3- (TRIFLUOROMETIL) FENIL] SOLUBILIZED BENZAMIDE USING ORGANIC ACIDS
UA109242U (en) STABLE PHARMACEUTICAL COMPOSITION CONTAINING PROTEASOM INHIBITOR
UA97982U (en) DRESSING MEDICINE FOR TABLETS